Course / Antidepressants & Fertility
This course provides fertility specialists and intended parents with a evidence-based analysis of the complex relationship between Selective Serotonin Reuptake Inhibitors (SSRIs) and fertility treatments. We will navigate the risks, benefits, and critical decision-making points for using these medications before and during ART cycles, with a specific focus on implications for surrogacy journeys.
Understand why SSRIs are a relevant and critical topic in a fertility clinic setting.
The Reality of Mental Health & Infertility: Infertility and the stress of treatment are significant psychological burdens. It is estimated that a substantial percentage of individuals undergoing fertility treatment experience clinical anxiety and/or depression.
SSRIs as First-Line Treatment: Selective Serotonin Reuptake Inhibitors (e.g., sertraline, escitalopram, fluoxetine) are the most commonly prescribed antidepressants due to their efficacy and generally favorable side-effect profile.
The Clinical Dilemma: The fundamental question we address is: Does the benefit of treating a parent’s mental health condition outweigh the potential reproductive risks of the medication? This module sets the stage for exploring this balance.
Learning Objective: Analyze the evidence regarding SSRI effects on ovulation, IVF outcomes, and pregnancy.
Potential Impact on Ovulation: Some studies suggest that SSRIs can subtly disrupt the hypothalamic-pituitary-ovarian (HPO) axis, potentially leading to altered menstrual cycles or anovulation in a subset of susceptible individuals. However, this is not a universal effect.
SSRIs and IVF Outcomes: The Data:
Fertilization & Embryo Quality: The current body of evidence shows no consistent, significant negative impact of SSRI use on fertilization rates or embryo quality.
Live Birth Rates: Meta-analyses have largely concluded that there is no definitive evidence that SSRIs significantly reduce the odds of achieving a live birth from an IVF cycle. However, some studies suggest a need for higher doses of gonadotropins.
Considerations During Pregnancy: For intended parents using their own gametes, we must discuss findings linking some SSRIs to a small increased risk of certain congenital anomalies (e.g., cardiac septal defects) and neonatal adaptation syndrome. These risks must be contextualized against the significant risks of untreated maternal depression.
Evaluate the often-overlooked effects of SSRIs on sperm parameters and male reproductive health.
Well-Established Impact on Semen Analysis: The most robust data regarding SSRIs and fertility pertains to males. Multiple studies demonstrate that SSRIs can cause:
Decreased Sperm Motility: A significant reduction in the percentage of sperm that are moving properly.
Increased DNA Fragmentation: Damage to the genetic material within the sperm head, which is linked to lower fertilization rates, poor embryo quality, and increased miscarriage risk.
Clinical Recommendation for Intended Fathers: For intended fathers providing sperm, a pre-treatment semen analysis is recommended. If on an SSRI and parameters are suboptimal, collaboration with a prescribing physician to discuss alternatives (e.g., switching to a different medication class like bupropion) or a planned medication holiday may be warranted.
Formulate a clear, patient-centered management plan for intended parents using SSRIs.
The Golden Rule: Do No Harm (Including Mental Harm): The risks of abruptly stopping an SSRI (severe depression relapse, anxiety, withdrawal symptoms) almost always outweigh the potential, and often uncertain, reproductive risks. Patients should never discontinue medication without their psychiatrist’s supervision.
The Collaborative Care Model: Optimal outcomes are achieved through a triad partnership: the Intended Parent(s), the Fertility Specialist, and the Prescribing Psychiatrist.
Strategic Management Options:
Maintain Current Regimen: Often the best choice for stable, well-managed patients.
Dose Adjustment/Optimization: Working with the psychiatrist to find the lowest effective dose.
Medication Switch: Transitioning to an antidepressant with a more favorable reproductive profile (e.g., bupropion for males).
Pre-Treatment “Washout” Period (Rare): A carefully managed, temporary discontinuation may be considered in specific cases (e.g., for male factor) but requires intense psychiatric oversight.
The Critical Role in Surrogacy: For gestational surrogacy journeys, the mental health of the Intended Parents is paramount for a stable and successful partnership with the surrogate. Ensuring their psychological well-being through appropriate treatment is a cornerstone of the process.
Synthesize the course material into actionable clinical pearls.
Screen for Mental Health: Proactively ask intended parents about their mental health and medication use.
Counsel on the Evidence: Provide balanced, evidence-based information on the real, but often modest, risks associated with SSRIs.
Prioritize Collaboration: Foster a strong referral network with reproductive psychiatrists.
Individualize the Plan: There is no one-size-fits-all approach. The decision must be tailored to the specific intended parent’s psychiatric history, fertility diagnosis, and treatment goals.
Affirm the Goal: The ultimate goal is a healthy baby and healthy, emotionally well parents. Properly managed mental health is an integral part of achieving this outcome.
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Secret Guide to Minimizing Surrogacy Costs
All Rights Reserved to Surrogacy4all
RESOLVE: The National Infertility Association, established in 1974, is dedicated to ensuring that all people challenged in their family building journey reach resolution through being empowered by knowledge, supported by community, united by advocacy, and inspired to act.
ASRM is a multidisciplinary organization dedicated to the advancement of the science and practice of reproductive medicine. The Society accomplishes its mission through the pursuit of excellence in education and research and through advocacy on behalf of patients, physicians, and affiliated health care providers.
Welcome to the Parent Guide: Starting Life Together, for children and their caregivers. Whether you are a mother or father (through birth, adoption, or foster care), a grandparent, partner, family friend, aunt or uncle with parenting responsibilities, the Parent Guide has information to help you through the FIRST FIVE YEARS of your parenting journey.
Path2Parenthood (P2P) is an inclusive organization committed to helping people create their families of choice by providing leading-edge outreach programs.
The FDA is a part of the Department of Health and Human Services.
Each day in America, you can trust the foods you eat and the medicines you take, thanks to the U.S. Food and Drug Administration.